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Abstract
Herpes simplex virus type 1 (HSV-1) can enter cells via endocytic pathways or direct fusion at the plasma membrane
depending on the cell line and receptor(s). Most studies into virus entry have used cultured fibroblasts but since
keratinocytes represent the primary entry site for HSV-1 infection in its human host, we initiated studies to characterize the
entry pathway of HSV-1 into human keratinocytes. Electron microscopy studies visualized free capsids in the cytoplasm and
enveloped virus particles in vesicles suggesting viral uptake both by direct fusion at the plasma membrane and by
endocytic vesicles. The ratio of the two entry modes differed in primary human keratinocytes and in the keratinocyte cell
line HaCaT. Inhibitor studies further support a role for endocytosis during HSV-1 entry. Infection was inhibited by the
cholesterol-sequestering drug methyl-b-cyclodextrin, which demonstrates the requirement for host cholesterol during virus
entry. Since the dynamin-specific inhibitor dynasore and overexpression of a dominant-negative dynamin mutant blocked
infection, we conclude that the entry pathways into keratinocytes are dynamin-mediated. Electron microscopy studies
confirmed that virus uptake is completely blocked when the GTPase activity of dynamin is inhibited. Ex vivo infection of
murine epidermis that was treated with dynasore further supports the essential role of dynamin during entry into the
epithelium. Thus, we conclude that HSV-1 can enter human keratinocytes by alternative entry pathways that require
dynamin and host cholesterol.
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Introduction
Herpes simplex virus type 1 (HSV-1) enters its human host via
epithelia of mucosa, skin or cornea where keratinocytes represent
the primary entry site. Cellular entry of HSV-1 involves multiple
steps. Initial virus-cell contact is mediated by HSV-1 envelope
glycoproteins gC and/or gB with cell surface heparan sulfate
proteoglycans which facilitate subsequent binding to coreceptors.
The viral envelope glycoprotein gD serves as the major virus
ligand for all known HSV coreceptors and the best studied gD
coreceptor is the immunoglobulin-like cell-cell adhesion molecule
nectin-1 (named HveC) [1]. Depending on the cell line HSV-1 can
enter cells either by direct fusion of the viral envelope with the
plasma membrane or by endocytic pathways [2,3,4,5] which can
be both pH-dependent and pH-independent [6]. Entry into
neurons and Vero cells can occur via fusion at the plasma
membrane at neutral pH while fusion with HeLa and CHO cells
involves pH-dependent endocytosis, and fusion with C10 (B78-H1
mouse melanoma expressing nectin-1) cells involves pH-indepen-
dent endocytosis. Interestingly, expression of nectin-1 in CHO
cells correlates with endocytic uptake while expression of PILRa
(paired immunoglobulin-like type 2 receptor a) in CHO cells
points to HSV-1 uptake via fusion suggesting that the entry
pathway into the same cell line depends on the cellular entry
coreceptor used [7]. Furthermore, the same receptor may initiate
different entry pathways, depending on the cell in which it is
expressed. When expressed in the J1.1-2 cell line, nectin-1
mediates entry that is not blocked by endosome acidification
inhibitors, however, nectin-1 mediated entry into CHO cells is
dependent on endosome acidification [2]. After additional
overexpression of avb3-integrin, HSV-1 entry in J1.1-2 nectin-1
cells is cholesterol- and dynamin-independent whereas cholesterol
and dynamin play a role in CHO-nectin-1 expressing cells [8]. A
phagocytosis-like uptake in which dynamin-mediated processes
have been implicated, has been also suggested for CHO-nectin-1
expressing cells [9]. Dynamin is a multidomain GTPase that
controls several distinct endocytic pathways, with the clathrin-
mediated endocytosis being the best studied [10]. Dynamin plays a
direct role in catalyzing membrane fission. During clathrin-
mediated endocytosis dynamin forms a helical polymer around the
vesicle neck and, upon GTP hydrolysis, mediates the fission of the
vesicle from the plasma membrane [11]. Recent studies have also
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implicated dynamin in further cellular processes such as regulation
of actin assembly and reorganization via its interactions with many
actin-binding proteins [12,13]. Furthermore, dynamin can
function in the process of fusion pore expansion and postfusion
events in exocytosis [14,15].
HSV-1 seems to be capable of using a variety of entry
mechanisms that may reflect an adaptation to differences in its
target cells. The goal of this study was to characterize the HSV-1
entry mechanisms into human keratinocytes since little is known
about this entry portal in the human host. There has been one
report that HSV-1 may enter keratinocytes via a pH-dependent
endocytic pathway [4]. The authors showed that treatment with
agents that elevate endosomal pH inhibits entry, and cellular
tyrosine kinase activity is selectively required for efficient entry by
the low-pH, endocytic pathway [4].
Our results suggest that HSV-1 enters human keratinocytes
both by direct fusion of virions at the cell surface and by an
endocytic pathway. As dynamin is an important player during
endocytic uptake we addressed its impact during entry into
keratinocytes. Interestingly, dynamin inhibitors blocked infection
by interfering with penetration of the virions at the plasma
membrane which in turn inhibited both fusion at the plasma
membrane and vesicle formation. Furthermore, we provide the
first evidence that host cholesterol plays an important role during
entry into keratinocytes.
Results
Uptake of HSV-1 into human keratinocytes
We infected HaCaT cells representing undifferentiated human
keratinocytes, and primary human epidermal keratinocytes to
analyze the mode of virus uptake using electron microscopy. All
studies were performed with high MOI (200 or 1500 PFU/cell) to
achieve infection of all cells at rather high cell density. Primary
keratinocytes were cultured in calcium-reduced medium to
minimize cell-cell contacts and thereby enhance infectivity.
At 2 min p.i. most virions were observed at the cell surface of
HaCaT cells while 24% of the virus particles were internalized.
Interestingly, 5% were found in vesicles and 19% were
detectable as free capsids underneath the plasma membrane
(Fig. 1A, C). The same ratio of free capsids and enveloped
particles in vesicles was present in primary keratinocytes
although at much lower percentages suggesting that virus uptake
was initially delayed as compared to HaCaT cells (Fig. 1B, C). At
10 min p.i. the same quantity of either free capsids or of particles
in vesicles were observed in HaCaT cells while by 30 min p.i.
free capsids were more abundant than particles in vesicles
(Fig. 1C). In contrast, the percentage of free capsids in primary
keratinocytes was significantly lower than the percentages of
particles in vesicles at 10 and 30 min p.i. (Fig. 1C). The results
suggest that uptake of HSV-1 into keratinocytes can occur via
both direct fusion of the viral envelope with the plasma
membrane and via an endocytic pathway. Interestingly, the
ratio between the two uptake modes differed in primary cells
compared with HaCaT cells suggesting that endocytic uptake is
more pronounced in primary keratinocytes.
We assume that the free capsids observed in the cytoplasm at
2 min p.i. were released following very rapid fusion at the plasma
membrane. Many of the capsids observed at 2 and 10 min p.i.
were located just underneath a region of the plasma membrane
with a distinctive staining pattern resembling that of the viral
envelope (Fig. 1 A, b, c; B, b). This is highly suggestive of a direct
fusion process. However, some of the free capsids observed at 10
and 30 min p.i. might be released from endosomes.
Role of endocytic pathways
The potential role of endosomal HSV-1 uptake into keratino-
cytes was analyzed by inhibitor studies. Successful infection in
individual cells was visualized by staining with an antibody
directed against the viral immediate-early protein ICP0. The
cellular localization of ICP0 passes through distinct phases during
early infection, in which ICP0 in nuclear foci indicates an early
stage of viral gene expression followed by a cytoplasmic ICP0
relocalization [16]. Therefore, a reduction in the amount of
cytoplasmic ICP0 following drug treatment suggests delayed
infection, although we cannot exclude the possibility that any
one drug could have an effect on export of ICP0 from the nucleus.
Subconfluent cells were infected with 20 PFU/cell which led to
,80–90% of HaCaT cells and,40–60% of primary keratinocytes
becoming infected based on ICP0 expression visualized at 2 h p.i.
When the microtubule-depolymerizing drug nocodazole which
inhibits trafficking from early to late endosomes [17], was added
prior to infection, the number of infected HaCaT cells was
reduced in a concentration-dependent manner from 83% to 58%.
The reduction was more marked when the MOI was lowered from
20 to 5 PFU/cell. In addition, the proportion of infected cells with
cytoplasmic ICP0 decreased from 40% to 6% (20 PFU/cell) in
drug-treated cells suggesting a delay of infection during the early
phase (Fig. 2A). When primary human keratinocytes were treated
with the same amounts of nocodazole, infection was reduced from
51% to 33% at 20 PFU/cell and from 42% to 15% at 5 PFU/cell
(Fig. 2B). Thus, our results support a role for trafficking via the
microtubule network in the entry pathway in keratinocytes.
However, this experiment does not distinguish between trafficking
of free capsids or trafficking of vesicles containing enveloped
particles from early to late endosomes.
Cells were treated with lysosomotropic agents to address the
impact of endosomal acidification during HSV-1 entry into
keratinocytes. While treatment of HaCaT cells with the carboxylic
ionophore monensin (40 mM) did not interfere with infectivity,
addition of the weak base ammonium chloride (NH4Cl) reduced
the level of infection from 87% to 47% of cells in a concentration-
dependent manner (Fig. 2C). In addition, the decrease in
cytoplasmic ICP0 localization in NH4Cl-treated HaCaT cells
suggested delayed early infection (Fig. 2C). In primary keratino-
cytes the concentration-dependent effect of NH4Cl was much
stronger. We observed a reduction in the number of infected cells
from 39% to 3% in the presence of 75 mM NH4Cl (Fig. 2D). In
contrast to HaCaT cells monensin-treatment of primary kerati-
nocytes also decreased the number of infected cells from 45% to
26% (Fig. 2D). There was a concomitant reduction in the number
of infected cells with cytoplasmic ICP0 in all drug-treated primary
cells. Taken together, the results demonstrate that NH4Cl
produced a limited and monensin no reduction in virus infectivity
in HaCaT cells, while both agents had much greater effects in
primary keratinocytes.
Control experiments indicated that the reduction in infectivity
by NH4Cl was reversible when the weak base was removed just
prior to infection (data not shown). Based on DAPI staining of the
cell nucleus, the chromatin seemed to be changed in the presence
of NH4Cl. To exclude the possibility that the observed effects were
due to a transcriptional block, GFP-expressing plasmids were
transfected which demonstrated unchanged GFP expression in
NH4Cl-treated HaCaT cells (data not shown). Furthermore, we
analyzed the localization of HSV-1 in NH4Cl-treated primary
keratinocytes to confirm that the elevated pH in intracellular
compartments interferes with the delivery of capsids to the nuclear
periphery as recently described [4]. Since in untreated control cells
nuclear accumulation of newly synthesized capsid protein VP5 was
Entry of HSV-1 into Human Keratinocytes
PLoS ONE | www.plosone.org 2 October 2011 | Volume 6 | Issue 10 | e25464
observed already early during infection, we inhibited protein
expression by cycloheximide to visualize input capsids in close
proximity to the nucleus (Fig. 3). In contrast, input capsids were
widely dispersed in NH4Cl-treated cells and localized only rarely
to the nuclear periphery (Fig. 3). In summary, we conclude that
endosomal acidification contributes to HSV-1 infection of HaCaT
cells and may play a more prominent role in primary
keratinocytes.
To gain further insights into potential endocytic pathways,
keratinocytes were treated with chlorpromazine which leads to
misassembly of clathrin-coated pits by inhibiting the assembly of
the clathrin adaptor protein AP2 [18]. Since treatment of HaCaT
cells with 28 mM chlorpromazine had no influence on infectivity
(Fig. 2E), we infer that clathrin-mediated endocytosis does not
contribute to HSV-1 entry. We then treated HaCaT cells with the
sodium-proton exchange inhibitor 5-(N-Ethyl-N-isopropyl)amilor-
Figure 1. Uptake of HSV-1 into human keratinocytes. (A) HaCaT cells or (B) primary human keratinocytes (phK) were incubated with HSV-1 at
200 PFU/cell (A, a, b), or 1500 PFU/cell (A, c, d; B, a–d) for 1 h at 4uC to allow attachment followed by incubation at 37uC to allow uptake. Cells were
fixed and prepared for electron microscopy at 2, 10, or 30 min p.i. (A, B) Particles on the cell surface (a), free cytoplasmic capsids (b, c) and enveloped
particles in vesicles (d) are shown at 2 and 10 min p.i. Bar, 0.2 mm. (C) In two independent experiments 133, 138, and 109 particles in total were
evaluated at 2, 10, and 30 min, respectively, in HaCaT cells, and 159 (at 2 min) and 254 (at 10 min) were analyzed in primary human keratinocytes.
The percentages of particles on the surface, cytoplasmic capsids and enveloped particles in vesicles are given at 2, 10, and 30 min p.i. Results are
mean 6 standard deviation values. In primary keratinocytes 58 particles in total were analyzed in one experiment at 30 min p.i.
doi:10.1371/journal.pone.0025464.g001
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ide (EIPA) which is used as specific inhibitor of macropinocytosis
[19]. The number of infected cells dropped from 90% to 61%
when 75 mM EIPA was added prior to infection (Fig. 2E). Recent
studies indicate that EIPA has significant effects on various
endocytic processes such as relocalization of early and late
endosomes [20]. Thus, the reduction in infectivity caused by
Figure 2. HSV-1 infection of keratinocytes pretreated with inhibitors against microtubules, actin, clathrin, sodium/proton
exchanger or with lysosomotropic agents. HaCaT cells or primary human keratinocytes were pretreated with the indicated concentrations of
drugs or corresponding solvent controls (C) for 30 min followed by infection with HSV-1 in the presence of the drugs. All infections were at 20 PFU/
cell apart from the nocodazole (noc)-treated cells which were infected both at 20 and 5 PFU/cell. All cells were fixed at 2 h p.i. and stained with
mouse anti-ICP0. The number of ICP0-expressing cells was determined in at least three independent experiments. The location of ICP0 expression
was recorded as only in the nucleus (nuclear ICP0) or in both nucleus and cytoplasm (cytoplasmic ICP0) representing early and early-late phases
during infection, respectively. The percentages of infected cells are shown after treatment with nocodazole (noc) in panels A and B, with NH4Cl and
monensin (mon) in C and D, and with chlorpromazine (CPZ), EIPA and cytochalasin D (CD) in E and F. Results are mean 6 standard deviation values.
P-values (pair-t-test) are given above the diagram (B, D).
doi:10.1371/journal.pone.0025464.g002
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EIPA may simply reflect the interference with an endocytic
pathway. Since macropinosome formation involves filamentous
actin (F-actin), keratinoyctes were treated with cytochalasin D
(CD) which blocks actin polymerization at the barbed ends of F-
actin. In both HaCaT cells and primary keratinocytes CD
treatment did not reduce the number of infected cells, although,
early infection seemed to be delayed in a concentration-dependent
manner (Fig. 2E, F). These results suggest that macropinocytosis is
not favored during HSV-1 entry into either HaCaT cells or
primary keratinocytes.
In summary, the inhibitor studies suggest that the microtubule
network and endosomal acidification contribute to the HSV-1
entry pathway in keratinocytes. The ion-transport inhibitor EIPA
had some inhibiting effect on infectivity whereas disassembly of
actin filaments correlated with only a minor effect on infection
which does not support a major role for the macropinocytic
pathway but indicates involvement of other endocytic processes.
Taking these results together we conclude that endocytic pathways
play a role during HSV-1 entry into keratinocytes.
Impact of cholesterol
Many endocytic pathways require cholesterol-rich lipid rafts for
their function. The essential role of cholesterol for HSV-1 entry
into Vero cells and mouse melanoma cells expressing either
nectin-1 or HVEM has been shown [21]. We treated keratinocytes
with methyl-b-cyclodextrin (MbCD) which depletes cholesterol
from the plasma membrane to address the requirement for
cholesterol for HSV-1 entry in keratinocytes [22,23,24]. The
functionality of MbCD in keratinocytes was initially confirmed by
visualizing the uptake of cholera toxin B, a glycosphingolipid-
binding ligand that is known to be internalized by caveolae-
mediated and lipid-raft-dependent endocytosis [25,26]. When
HaCaT cells were pretreated with 15 mM MbCD for 30 min
cholera toxin B uptake was efficiently blocked as visualized by the
loss of cytoplasmic cholera toxin B (Fig. 4D). Upon HSV-1
infection a concentration-dependent inhibition of infectivity was
visible in both MbCD-treated HaCaT cells and primary
keratinocytes. Upon pre-treatment with 10 mM MbCD the
number of infected cells was reduced from 88% to 16% in
HaCaT cells and from 64% to 22% in primary keratinocytes
(Fig. 4B). Prior to infection MbCD was removed to avoid any
depleting effect on cholesterol in the viral envelope. Control
experiments indicate that preincubation of HSV-1 particles with
10 mMMbCD reduced infectivity (Fig. 4A). This observation is in
agreement with previous results demonstrating a reduced infection
rate of pseudorabies virus (PrV) when viral cholesterol was
depleted with MbCD [27]. When 10 mM MbCD was added to
the cells at 1 h p.i., we observed no effect on the number of
infected cells (Fig. 4C) suggesting that depletion of cholesterol in
the plasma membrane interferes directly with HSV-1 uptake and
that MbCD does not disturb subsequent steps during early
infection. In addition, we addressed whether cholesterol depletion
was reversible by giving 50 or 200 mg/ml cholesterol to MbCD-
treated cells. Following infection we observed a concentration-
dependent increase in infectivity (Fig. 4C) demonstrating that
replenishment of cholesterol restored infectivity.
When filipin which binds cholesterol was used, we observed a
reduction in the number of infected primary keratinocytes,
however, no effect was visible in HaCaT cells (data not shown).
Since filipin also failed to inhibit cholera toxin B uptake into
HaCaT cells we conclude that filipin insufficiently sequestered
cholesterol in these cells.
Taken together, these results indicate that cholesterol in the
plasma membrane is required for HSV-1 uptake into keratinocytes.
Impact of dynamin
The GTPase dynamin controls several distinct endocytic
pathways [11]. To determine the role of dynamin during HSV-1
uptake, we performed overexpression, RNA interference and
inhibitor studies. To overexpress the dominant-negative dynamin
mutant K44A [28], HaCaT cells were transfected with plasmids
expressing either the GFP-tagged dynamin mutant or GFP alone
followed by infection. At 2 h p.i. we observed a reduced number of
infected cells in the presence of the overexpressed dynamin
mutant. Whereas 78% of the GFP-expressing cells became
infected, the presence of the overexpressed dominant-negative
dynamin mutant reduced the number of infected cells to 16%
(Fig. 5A, B). In contrast, overexpression of wt dynamin had no
inhibitory effect (data not shown).
In keratinocytes the ubiquitously expressed dynamin 2 is
present, while dynamin 1 expression is restricted to neurons and
dynamin 3 is expressed in lung, heart, brain and testis. When we
reduced dynamin 2 expression in HaCaT cells, almost no effect on
infection was observed (data not shown). Since dynamin 2
expression was only reduced by ,80% after silencing, we
conclude that the residual amount of dynamin 2 was still sufficient
to allow viral entry.
Figure 3. Localization of HSV-1 particles in NH4Cl-treated primary human keratinocytes cells. Untreated cells (control) or cells pretreated
with 75 mM NH4Cl were incubated with 100 PFU/cell of HSV-1 for 2 h at 4uC followed by incubation at 37uC. After 2 h at 37uC cells were either
treated with 0.1 mM cycloheximide or medium was replaced. After 5 h at 37uC cells were fixed and stained with mouse anti-VP5, visualized with
AF488-conjugated antimouse (Molecular Probes). Confocal projections are shown and nuclei stained with 49, 69-diamidino-2-phenylindole (DAPI) are
circled. Bar, 8 mm.
doi:10.1371/journal.pone.0025464.g003
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To further analyze the impact of dynamin we pretreated
keratinocytes with dynasore, a small molecule inhibitor of the
dynamin GTPase activity [29]. As a control we confirmed that
dynamin-dependent transferrin uptake was blocked in HaCaT
cells pretreated with 40 mM dynasore (Fig. 6A) [30,31]. When
dynasore was added either to HaCaT cells or primary keratino-
Figure 4. HSV-1 infection of keratinocytes upon depletion of cholesterol. (A) HaCaT cells were infected with HSV-1 pretreated with MbCD
(10 mM) for 30 min at room temperature or with untreated HSV-1 at 20 PFU/cell. (B) HaCaT cells or primary human keratinocytes were pretreated
with the indicated concentrations of MbCD for 30 min at 37uC. After washing with medium cells were infected with HSV-1 at 20 PFU/cell. As a control
(C), cells were infected in the absence of the drug. (C) HaCaT cells were infected with HSV-1 at 20 PFU/cell. At 1 h p.i. 5 or 10 mM MbCD was added to
the cells. In addition, HaCaT cells were pretreated with 10 mM MbCD for 30 min, and 0, 50 or 200 mg/ml cholesterol was added prior to infection. (A,
B, C) At 2 h p.i. cells were fixed, stained with mouse anti-ICP0 and the number of ICP0-expressing cells was determined in at least three independent
experiments. Results are mean 6 standard deviation values. (D) HaCaT cells were untreated or pretreated with 15 mM MbCD for 30 min and AF594-
conjugated cholera toxin B (CT-B) (5 mg/ml) was added. Cells were fixed and stained with DAPI. Bar, 20 mm.
doi:10.1371/journal.pone.0025464.g004
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cytes a concentration-dependent inhibition of HSV-1 infection
was observed. However, while 20 mM dynasore almost completely
blocked infection of HaCaT cells (Fig. 6C, D), 80 mM dynasore
was needed to produce the same level inhibition in primary
keratinocytes (Fig. 6E, F). When dynasore (80 mM) was washed out
prior to infection, no inhibitory effect on the number of infected
cells was observed (data not shown). In contrast to keratinocytes,
no inhibitory effect was detectable when murine hippocampal
primary neurons were pretreated with up to 80 mM dynasore
(Fig. 6G). These results suggest that dynamin is essential for HSV-
1 entry into keratinocytes but does not play a role during entry into
neurons.
To exclude any direct effects of dynasore on virus particles, we
analyzed the infectivity of dynasore pretreated virions. No
difference in the number of infected cells was visible when HaCaT
cells were infected with untreated or dynasore-pretreated particles
(Fig. 6B) confirming that dynasore interfered only with cellular
functions. As a further control to rule out possible adverse actions
of dynasore itself, we analyzed the effect of MiTMAB, a surface-
active inhibitor that blocks dynamin’s interactions with phospho-
lipids [32]. Upon pre-treatment of HaCaT cells with MiTMAB
(1–20 mM) a concentration-dependent inhibition of infection was
detectable which was comparable to the effects observed in
dynasore-treated cells (data not shown).
EM studies were performed to determine how dynasore affected
the uptake mechanisms during HSV-1 entry into keratinocytes. As
a precondition for the EM studies we tested whether dynasore
blocked infection at the high MOIs needed for EM analysis of
incoming virus particles. Infection studies with 1500 PFU/cell
showed that 120 mM dynasore still blocked infection, while
DMSO alone had no effect (Fig. 7B). As expected, the patterns
of virus uptake at 10 min p.i. in cells pretreated with DMSO were
comparable with those shown for untreated cells with both free
capsids and particles in vesicles being observed in the cytoplasm
(Fig. 7A a–b, D a–b). In contrast, when primary keratinocytes were
pretreated with dynasore we observed virus particles almost
exclusively on the outside of the cells at both 10 and 30 min p.i.
(Fig. 7A e–h). These particles were predominantly located in
invaginations at the plasma membrane, unlike particles that were
attached to the cell surface upon incubation for 1 h at 4uC (Fig. 8A
c–d). Quantification revealed that there was no increase in the low
number of internalized particles in dynasore-treated cells between
10 and 30 min p.i. by which time about 81% of the observed
particles had been taken up in control cells (Fig. 7C). Surprisingly,
the few internalized particles in dynasore-treated cells included
both free capsids underneath the plasma membrane and
enveloped particles in vesicles. Dynasore has been reported to
stabilize pit formation at the plasma membrane at early and late
stages [29]. Therefore, we had assumed that the uptake of particles
via fusion of their envelopes with the plasma membrane would not
be blocked in dynasore-treated keratinocytes. Since cytoplasmic
capsids were more often found in infected HaCaT cells than in
primary keratinocytes, we looked for the presence of free capsids in
dynasore-treated HaCaT cells at 10 min p.i., by which time
approximately 20% of particles in untreated cells would be free
capsids in the cytoplasm (Fig. 1C). Surprisingly, as in primary
keratinocytes, virus particles were only found on the cell surface in
invaginations of the plasma membrane (Fig. 7D, E). Thus, we
conclude that dynasore blocks both modes of uptake fusion with
the plasma membrane and endocytosis.
Using a recently established protocol for ex vivo infection of
murine epidermal sheets [16], we investigated whether infection of
a target tissue is also dynamin-dependent. Skin from the backs of
newborn mice was prepared, and the epidermis was separated
from the dermis by dispase treatment. The epidermal sheets were
allowed to float on virus-containing medium supplemented with
DMSO alone, or with 40 or 120 mM dynasore. At 3 h p.i.
costaining of keratin 14 and ICP0 revealed infection throughout
the basal layer of keratinocytes in the DMSO-treated epidermis
(Fig. 8). In contrast, infection was blocked in a concentration-
dependent manner when the epidermal sheets were pretreated
with dynasore (Fig. 8). These results support the essential role of
dynamin for HSV-1 entry into basal keratinocytes of the
epidermis.
In summary, we conclude that dynamin plays an essential role
during HSV-1 uptake into keratinocytes.
Discussion
HSV-1 can use a variety of entry modes all depending on a set
of envelope viral glycoproteins [1]. Whether the virus can
Figure 5. HSV-1 infection of HaCaT cells transfected with the dynamin1 mutant K44A. (A) Cells were transfected with plasmids either
expressing the green-fluorescent protein (control) or the green-fluorescent protein fused to the dominant-negative dynamin1 mutant (K44A). At 22 h
posttransfection the cells were infected with HSV-1 (50 PFU/cell). At 2 h p.i. cells were fixed and stained with mouse anti-ICP0 (red) visualized with
AF555-conjugated anti-mouse (Molecular Probes). Bar, 40 mm. (B) The number of ICP0-expressing cells per K44A-expressing cell was determined in
three independent experiments. As a control, the number of infected cells that were expressing eGFP is shown. The percentages of infected cells that
were expressing the indicated plasmids are given. Results are mean 6 standard deviation values.
doi:10.1371/journal.pone.0025464.g005
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accomplish more than one entry pathway to infect any particular
target cell, is still unclear. In this study, we investigated the entry
pathway(s) into human keratinocytes which represent one of the
natural target cells for HSV-1. Initial EM studies revealed free
capsids underneath the plasma membrane in addition to
enveloped virus particles in vesicles suggesting that HSV-1 can
enter keratinocytes both by fusion with the plasma membrane and
by endocytosis. The challenge is to distinguish whether both or
only one of these entry pathways led to productive infection. We
initially investigated the impact of endocytic uptake for initiation
of infection using a variety of pharmacological inhibitors. In
general, the major advantage of pharmacological inhibitors is the
short exposure time that delays compensatory responses of the
cells. However, the poor specificity of many commonly used drugs
can hamper the identification of the precise endocytic pathway
involved in virus uptake since they may perturb multiple cellular
processes. To minimize this problem we used a range of drugs at
concentrations that have been shown to interfere with virus uptake
without major side effects. We confirmed that the concentrations
of the drugs used in our assays had neither cytotoxic effects nor
caused morphological changes in keratinocytes. Our data support
endocytic uptake as contributing to HSV-1 entry, although, we are
only just beginning to identify the components which characterize
the route(s) of uptake.
Our studies in chlorpromazine treated cells showed no effect on
the number of infected cells and suggest that clathrin-mediated
endocytosis does not play a role in HSV-1 entry into keratinocytes.
In contrast, we observed a decreased number of infected cells after
treatment with EIPA. EIPA can inhibit the enhanced fluid phase
uptake that is associated with particle invagination during
macropinocytosis [19]. Macropinocytosis is utilized for entry by
a number of pathogens [33,34], and has been suggested to be
involved in Kaposi’s sarcoma-associated herpesvirus entry [35].
To further examine the putative role of macropinocytosis in HSV-
1 entry we investigated the role of F-actin which is mostly
associated with macropinocytic activity using cytochalasin D [33].
Since interference with actin polymerization had only minor
effects on infection, our inhibitor studies do not support
macropinocytosis as a major uptake mechanism in keratinocytes.
This is in line with our previous findings that HSV-1 entry into
keratinocytes is independent of Rac1 signaling [16] which
participates in the regulation of macropinosome formation [33].
Based on reports showing that EIPA mediates a number of effects
on endocytic pathways [20,36], we conclude that the inhibitory
effect of EIPA points in general to the involvement of endocytic
uptake but not to macropinocytosis specifically.
A decreased number of infected cells was observed when we
analyzed the effects of the microtubule-disrupting agent nocoda-
zole in both HaCaT cells and primary keratinocytes. The
importance of the microtubule network for the transport of
capsids to the nucleus during HSV-1 entry has been shown
previously [37]. Concomitantly, endosomal trafficking also relies
on the integrity of the microtubule network [38]. Thus, our studies
support a role for microtubules during HSV-1 entry into
keratinocytes but do not distinguish between one initiated by
fusion with the plasma membrane and releasing capsids into the
cytosol or one involving endocytic uptake and vesicle transport.
It has previously been reported that endosomal acidification is
required to release HSV-1 after endocytic uptake in keratinocytes
[4]. We also observed that lysosomotropic agents such as NH4Cl
and monensin reduced infection in primary keratinocytes.
However, although NH4Cl also reduced infectivity in the
keratinocyte cell line HaCaT, only minor effects were observed
with monensin. These studies suggest that endosomal acidification
plays a more prominent role in primary keratinocytes. This is in
line with our EM studies which showed that more virus particles
were found in vesicles than as free capsids in primary cells as
compared to HaCaT cells. Although our results are consistent with
the previously described effect of NH4Cl, they differ from those
described for monensin [4] which may be explained by the
different experimental setting.
Taken together our inhibitor studies support pH-dependent
endocytic pathway(s) as a route for HSV-1 uptake into
keratinocytes leading to productive infection. Interestingly,
endocytic uptake seems to be more pronounced in primary
keratinocytes than in the keratinocyte cell line highligthing the
importance of carrying out studies in primary cells. Although our
EM studies suggest that uptake of HSV-1 by fusion with the
plasma membrane occurs alongside endocytosis, it remains to be
determined whether and to what extent the direct fusion pathway
leads to successful infection. The observation that the inhibitors of
endocytosis never blocked infection completely but only reduced
the number of infected cells or simply delayed infection may be an
early indication that fusion at the plasma membrane can also lead
to infection.
Our studies revealed a requirement for cholesterol for HSV-1
uptake in keratinocytes. The depletion of cholesterol from the
plasma membrane by MbCD resulted in inhibition of infectivity
which was slightly stronger in HaCaT cells than in primary
keratinocytes. The availability of cholesterol may be different in
primary keratinocytes and HaCaT cells. The requirement for
cholesterol suggests that lipid rafts may play an essential function
in HSV-1 uptake into keratinocytes. Recent studies suggest that
lipid rafts act as platforms for HSV-1 entry into Vero cells and
mouse melanoma cells expressing either nectin-1 or HVEM
involving the interaction of gB with cellular components in the
rafts [21]. Interestingly, the HSV-1 receptors nectin-1 and HVEM
were not found to be associated with lipid rafts when expressed in
mouse melanoma cells. Thus, Bender et al. [21] argued that
cholesterol may be required for fusion with the plasma membrane
independent of whether the virus receptors are present in lipid
rafts or not. Whether nectin-1, a potential HSV-1 receptor in
HaCaT cells [39] is localized to lipid rafts in human keratinocytes,
is still unknown. Our results suggest that cholesterol is essential
during HSV-1 uptake into keratinocytes and we hypothesize that
cholesterol supports both fusion with the plasma membrane and
endocytic uptake.
In addition to cholesterol our studies demonstrate the essential
role of dynamin during HSV-1 entry into keratinocytes. Dynasore,
a specific inhibitor of the dynamin GTPase activity [29,40],
Figure 6. HSV-1 infection of dynasore-treated cells. All pretreatments with DMSO or dynasore were carried out for 30 min at 37uC. (A) HaCaT
cells were pretreated with 0.4% DMSO or 40 mM dynasore and 50 mg/ml AF488-conjugated transferrin (Tfn) (green) was added for 15 min. Cells were
fixed and stained with DAPI. Confocal projections are shown. Bar, 40 mm. (B) HSV-1 pretreated with DMSO (0.4%) or dynasore (40 mM) was used to
infect HaCaT cells at 20 PFU/cell. (C, D) HaCaT cells, (E, F) primary human keratinocytes, or (G) primary hippocampal neurons were pretreated with
DMSO or the indicated concentrations of dynasore followed by infection with HSV-1 at 20 PFU/cell. (B–G) At 2 h p.i. cells were fixed and costained
with DAPI and mouse anti-ICP0 (green). Overlays of immunofluorescence analyses are shown. Bar, 80 mm. The number of ICP0-expressing cells was
determined in (D) HaCaT cells, and (F) primary human keratinocytes in at least three independent experiments. Results are mean 6 standard
deviation values.
doi:10.1371/journal.pone.0025464.g006
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blocked HSV-1 infection in HaCaT cells at low concentrations.
Interestingly, we observed that infection of primary keratinocytes
was less sensitive to dynasore inhibition, requiring levels four times
higher to achieve a reduction comparable to that seen in HaCaT
cells. This was unexpected since we supposed a more prominent
role of endocytic uptake in primary cells, and expected dynamin to
be involved in endocytic pathways. The high amount of dynasore
was also tested in primary murine neurons where no effect on
HSV-1 infection was observed. In principle, dynasore can block
endocytic pathways in hippocampal neurons [41]. Thus, dynamin
seems to be nonessential for HSV-1 entry into neurons, but plays a
major role during the uptake mechanism(s) into keratinocytes. We
also examined the requirement for dynamin in murine epidermis
using an ex vivo infection assay. After treatment of epidermal sheets
with dynasore we observed a block of ICP0 expression in the basal
keratinocytes suggesting that dynamin also plays a role during
entry of the virus into intact tissue. EM studies in primary
keratinocytes and HaCaT cells confirmed that neither free capsids
nor enveloped particles in vesicles were present inside dynasore-
treated cells. The only particles seen were enveloped virions
trapped in plasma membrane invaginations at the cell surface.
These results suggest that HSV-1 entry is completely dependent on
dynamin-mediated pathway(s) which appear to include both early
fusion events at the plasma membrane and vesicle scission. HIV,
another enveloped virus, has long been assumed to fuse directly at
the plasma membrane. Recent findings support HIV entry via
endocytosis and suggest a role of dynamin in HIV release from
endosomes [42]. The authors argue that the dynamin-dependent
fusion with endosomes could rely on the ability of dynamin to
regulate actin remodeling and/or associate with membrane-
bending proteins which might facilitate endosomal fusion [42].
However, a recent study suggests a role of dynamin in pore
expansion following hemifusion [15] which provides a possible
reason why HSV-1 fusion at the plasma membrane was blocked
Figure 7. Uptake of HSV-1 into dynasore-treated keratinocytes. Primary human keratinocytes and HaCaT cells were pretreated with 120 or
80 mM dynasore, and correspondingly with 1.2% or 0.8% DMSO for 30 min at 37uC followed by 15 min at 4uC to precool the cells. Cells were
incubated with HSV-1 (1500 PFU/cell) for 1 h at 4uC followed by incubation at 37uC. (A) Infected primary human keratinocytes were fixed and
prepared for electron microscopy at 10 min (a, b, e, f), or 30 min at 37uC (g, h). As control, DMSO-pretreatd cells were incubated with HSV-1
(1500 PFU/cell) for 60 min at 4uC (c, d). Bar, 0.2 mm. (B) At 2 h at 37uC infected primary human keratinocytes were fixed and costained with TRITC-
phalloidin (red) to visualize F-actin and mouse anti-ICP0. Single immunofluorescence analyses are shown. Bar, 40 mm. (C) Percentages of particles on
surface, and particles inside including free cytoplasmic capsids and enveloped particles in vesicles are shown in DMSO- or dynasore-treated primary
keratinocytes at 10 and 30 min at 37uC. In two independent experiments 108 (DMSO) and 122 (Dynasore) particles in total were evaluated for the
10 min time point and in one experiment 52 (DMSO) and 62 (Dynasore) particles were analyzed for the 30 min time point. (D) Infected HaCaT cells
pretreated with DMSO or dynasore were fixed and prepared for electron microscopy at 10 min at 37uC (a–c). Bar, 0.2 mm. (E) Percentages of particles
on surface, and particles inside are shown in DMSO- or dynasore-treated HaCaT cells at 10 min at 37uC. In two independent experiments 78 (DMSO)
and 76 (Dynasore) particles in total were evaluated. Results are mean 6 standard deviation values.
doi:10.1371/journal.pone.0025464.g007
Figure 8. HSV-1 infection of murine epidermis pretreated with dynasore. Epidermal sheets prepared from newborn mouse skin were
separated from dermis by dispase II treatment, followed by incubation on 40 or 120 mM dynasore-containing medium or DMSO-containing medium.
After 1 h at 37uC HSV-1 was added at 100 PFU/cell. At 3 h p.i. epidermal whole mounts showing the basal keratinocyte layer and developing hair
follicles were costained with mouse anti-ICP0 (red) and rabbit anti-keratin 14 (green) visualized with AF555-conjugated anti-mouse (Molecular
Probes) and AF488-conjugated anti-rabbit (Molecular Probes), respectively. Single immunofluorescence analyses are shown. Bar, 80 mm.
doi:10.1371/journal.pone.0025464.g008
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by dynasore. Probably, we are only at the beginning of
understanding the precise mechanisms underlying dynamin
function during viral uptake and that its role is more diverse than
presently perceived.
In summary, we suggest that HSV-1 uptake into human
keratinocytes involves endocytic pathway(s) and fusion at the
plasma membrane, and that both routes are dynamin-mediated
and cholesterol-dependent. To understand the underlying mech-
anisms it will be important to characterize the contribution of
nectin-1 and other HSV-1 receptors in human keratinocytes.
Methods
Cells, viruses, and plasmids
HaCaT cells [43] were maintained in DMEM (Invitrogen)
containing 10% fetal calf serum (FCS) and penicillin (100 IU/ml),
streptomycin (100 mg/ml). Primary human foreskin keratinocytes
were prepared and cultured on feeder layers as described [44]. In
brief, primary human keratinocytes were maintained in keratino-
cyte culture medium (Ham’s F12-DMEM (1:3); Invitrogen)
containing 1.8 mM calcium ions and 10% FCS, penicillin
(100 IU/ml), streptomycin (100 mg/ml), adenine (1.861024 M),
glutamine (2 mM), hydrocortisone (0.5 mg/ml), epidermal growth
factor (EGF 10 ng/ml), cholera enterotoxin (1025 M), insulin
(5 mg/ml) in the presence of mitomycin C treated 3T3 fibroblasts,
strain J2. DMEM/Ham’s F-12 (Biochrom) containing 50 mM
calcium and 10% calcium-free FCS was used as keratinocyte
culture medium to maintain the primary cells under calcium-
reduced conditions.
Hippocampal murine neuron cultures were prepared as
described [45]. In brief, hippocampi were dissected from
embryonic day 9 mice. After treatment with 0.1% trypsin and
150 mg/ml DNAse for 30 min at 37uC, cell suspensions were
mechanically dissociated by pipetting and finally centrifuged at
400 g for 5 min. About 20,000 cells were plated on poly-lysine
coated coverslips in B27 neurobasal medium supplemented with
1% L-glutamine. Cultures were maintained for about 10 days
before infection.
Murine epidermal sheets were taken from back skin of wild-type
(C57BL6) newborn mice. At 3 days after birth mice were
decapitated and skin pieces of about 15 mm diameter were taken.
After incubation for 30 min at 37uC with 5 mg/ml dispase II
(Roche) in PBS, the epidermis was washed three times in PBS,
gently removed from the underlying dermis as an intact sheet
using forceps, and used immediately for infection studies.
Infection studies were performed with purified preparations of
HSV-1 wildtype strain 17 as described [46]. In general, virus
inoculum was added to the cells at 37uC defining time point 0. In
addition, virus was preadsorbed for 1 or 2 h at 4uC as indicated.
Virus titers were determined on Vero cells. Pretreatment of virus
with 40 mM dynasore or 10 mM MbCD was performed for
30 min at 37uC or room temperature, respectively.
The expression vector encoding eGFP-tagged dynamin1 mutant
K44A was obtained from Harvey McMahon (MRC, Cambridge).
Plasmid EGFP-C1 (Clontech) was used as control.
Ethics statement
The preparation of neuronal cells and epidermal sheets from
sacrificed animals was carried out in strict accordance with the
recommendations of the Guide of Landesamt fu¨r Natur, Umwelt
and Verbraucherschutz, Nordrhein-Westfalen (Germany). The
study was approved by LANUV NRW (Number 8.84-
02.05.20.11.058).
Inhibitor studies
Cytochalasin D and nocodazole (Sigma), and the dynamin
inhibitors dynasore (Tocris) and MiTMAB (Calbiochem) were
dissolved in dimethyl sulfoxide (DMSO). Methyl-b-cyclodextrin
(MbCD) (Sigma) and chlorpromazine (Sigma) were dissolved in
water; monensin (Sigma) and 5-(N-Ethyl-N-isopropyl)amiloride
(EIPA) (Sigma) were dissolved in ethanol. Cells were treated with
the appropriate drugs for 30 min followed by infection at 37uC in
the continued presence of the drug. Only MbCD was removed
prior to infection by washing the cells with medium three-times.
Cholesterol (Sigma) was used to replenish depleted cholesterol in
the plasma membrane; cells pretreated with MbCD for 30 min at
37uC were washed three-times, and cholesterol was added for
30 min at 37uC followed by three further washing steps prior to
infection. Alexa Fluor 594-conjugated cholera toxin B (Molecular
Probes) served as control for the cholesterol-depleting function of
MbCD; cells pretreated with MbCD for 30 min at 37uC were
washed and incubated for 15 min at 4uC. After addition of AF594-
conjugated cholera toxin B, cells were incubated for 10 min at 4uC
followed by 10 min at 37uC and fixation. AF488-conjugated
transferrin (Molecular Probes) was used as a control for dynasore
inhibition. Transferrin was added to dynasore-treated or untreated
cells for 15 min at 37uC, and removed from the cell surface prior
to fixation by washing with 0.1 M glycine, 150 mM NaCl (pH 2.5)
prior to fixation [47].
Transient expression
For transfection, HaCaT cells were trypsinized, pelleted,
washed with PBS and resuspended in Nucleofector solution V
(Amaxa). Cells (,16106) were transfected with 2 or 4 mg of
plasmid in a cuvette, utilizing program U-20 of an Amaxa
Nucleofector I. Cells were seeded on coverslips and infected at
22 h posttransfection at 50 PFU/cell for 2 h.
Immunocytochemistry and antibodies
HaCaT cells and primary keratinocytes grown on coverslips
were fixed with 2% formaldehyde in PBS, permeabilized with
0.5% NP-40 and stained. At 2 h p.i. infected cells were visualized
by ICP0 staining with mouse anti-ICP0 (monoclonal antibody
11060) [48], diluted 1:60. Capsid protein VP5 was visualized with
monoclonal antibody DM165 [49], diluted 1:200. For immuno-
staining of epidermal wholemounts, murine epidermis was fixed
with 3.4% formaldehyde for 2 h, washed two times with PBS,
blocked with 0.5% milk powder, 0.25% gelatin from cold water
fish skin, 0.5% Triton X-100 in 0.2% PBS-Tween 20 for 1 h, and
then incubated overnight with mouse anti-ICP0 (monoclonal
antibody 11060) [48] diluted 1:60 and rabbit polyclonal anti-
mouse keratin 14 (AF64, Covance) diluted 1:100,000 followed by
overnight incubation with secondary antibodies at room temper-
ature. Staining of F-actin was performed with tetramethylrhoda-
mine isothiocyanate (TRITC)-conjugated phalloidin (Sigma).
Microscopy was performed using a Zeiss Axiophot, a Zeiss LSM
510 and a Leica DM IRB/E microscope linked to a Leica TCS-
SP/5 confocal unit. Images were aquired using Adobe Photoshop,
version CS2.
The effects of dynamin1 mutant K44A were quantified by
counting about 300 transfected cells visualized by GFP fluores-
cence in three independent experiments and calculating the
number of infected cells visualized by ICP0 staining.
Electron microscopy
Infected cells were prepared for electron microscopy as
described [50]. Thin sections were cut, stained with uranyl acetate
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and lead citrate, and analyzed in a JEOL 1200 EX II transmission
electron microscope. For quantification we examined sections of
0.1 mm. In each section we analyzed 80–100 cells with every third
cell showing at least one virus particle. For each time point and
experiment sections of about 30 cells with 60–90 virus particles in
total were evaluated.
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